12/16
07:05 am
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $37.00 price target on the stock.
Low
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $37.00 price target on the stock.
12/16
07:05 am
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $37.00 price target on the stock.
Low
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $37.00 price target on the stock.
12/16
06:57 am
dnli
Rating for DNLI
Low
Report
Rating for DNLI
12/16
06:22 am
dnli
Denali Therapeutics upgraded to Buy from Hold at Stifel
Low
Report
Denali Therapeutics upgraded to Buy from Hold at Stifel
11/7
08:36 am
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Low
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
11/1
01:04 pm
dnli
Rating for DNLI
Low
Report
Rating for DNLI
11/1
01:04 pm
dnli
Rating for DNLI
Low
Report
Rating for DNLI
10/11
10:03 am
dnli
Rating for DNLI
Medium
Report
Rating for DNLI
10/10
09:36 am
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "market perform" rating re-affirmed by analysts at Raymond James.
Low
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "market perform" rating re-affirmed by analysts at Raymond James.
10/10
09:36 am
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "market perform" rating re-affirmed by analysts at Raymond James.
Low
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "market perform" rating re-affirmed by analysts at Raymond James.
10/10
09:11 am
dnli
Rating for DNLI
Medium
Report
Rating for DNLI
10/10
09:11 am
dnli
Rating for DNLI
Medium
Report
Rating for DNLI
10/7
08:10 am
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) was downgraded by analysts at Cantor Fitzgerald from an "overweight" rating to a "neutral" rating.
Medium
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) was downgraded by analysts at Cantor Fitzgerald from an "overweight" rating to a "neutral" rating.